Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens

Journal of Medical Virology(2024)10.1002/jmv.29628Source: DataRank Database

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens is a research paper published in Journal of Medical Virology (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 4.83)OA: hybridTopics (48)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Maria K. Smatti ORCID,Haya Al‐Sulaiti ORCID,Hadeel T. Zedan ORCID,Ali H. Eid ORCID,Ali Ait Hssain ORCID

Live enrichment

PubMed:38682568 OpenAlex:https://openalex.org/W4395959963

This study was supported by partial funds from QU.

Grant: QUCG-BRC-2022/23-578

FWCI

4.83

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.29628

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.29628

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.29628

journalhttps://doi.org/10.1002/jmv.29628

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38682568

Fields of Study

SARS-CoV-2 and COVID-19 ResearchDiabetes and associated disordersMonoclonal and Polyclonal Antibodies Research

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAdultAgedAnimalsAntibodies, ViralAntigens, ViralFemaleHumansImmunoglobulin GMaleMiddle AgedNeutralization TestsVaccinationCoronavirus InfectionsAntibody-Dependent EnhancementAntibodies, NeutralizingSpike Glycoprotein, CoronavirusMiddle East Respiratory Syndrome Coronavirus

Keywords

Middle East respiratory syndrome coronavirusVirologyAntibodyVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)NeutralizationMedicineCoronavirusAntibody-dependent enhancementNeutralizing antibodyAntigenImmunologyBiologyCoronavirus disease 2019 (COVID-19)VirusViral replicationInfectious disease (medical specialty)DiseaseAntibody‐dependent EnhancementMers‐covCovid‐19Sars‐cov‐2FcgriiaNon‐neutralizing AntibodiesCross‐reactive Antibodies

Sustainable Development Goals

SDG 0: Good health and well-being